A modification of the basic immunofluorescent staining and flow cytometric analysis protocol can be used for the simultaneous analysis of surface molecules and intracellular antigens at the single-cell level. In this protocol, cells are first activated in vitro, stained for surface antigens as in the surface antigen protocol, then fixed with paraformaldehyde to stabilize the cell membrane and permeabilized with the detergent saponin to allow anti-cytokine antibodies to stain intracellularly. In vitro stimulation of cells is usually required for detection of cytokines by flow cytometry since cytokine levels are typically too low in resting cells. Stimulation of cells with the appropriate reagent will depend on the cell type and the experimental conditions. For example, to stimulate T cells to produce IFN-γ, TNF-α, IL-2, and IL-4, a combination of PMA (a phorbol ester / PKC activator) and Ionomycin (a calcium ionophore) or anti-CD3 antibodies can be used. To induce IL-6, IL-10 or TNF-α production by monocytes, stimulation of PBMC’s with lipopolysaccharide (LPS) can be used.Note: Optimal stimulation period for induction of a given cytokine is variable and has to be determined. For example, the best time for detection of IL-6-producing cells by human LPS-activated monocytes is 6 hours, whereas IL-10 detection needs at least 24 hours stimulation.In contrast to detection of secreted cytokines by ELISA, for detection of intracellular cytokines, it is necessary to block secretion of cytokines with protein transport inhibitors, such as Monensin or Brefeldin A, during the last few hours of the stimulation. It is advised that the investigators evaluate the use and efficacy of different protein transport inhibitors in their specific assay system.Note: Generally, the non-specific background staining of fixed and permeabilized cells is higher than surface staining; therefore, extra protein such as BSA or FCS can be included in the staining buffer. The optimal concentration of the fluorochrome-conjugated anti-cytokine antibodies has to be determined experimentally. To confirm specificity of the staining, it is useful to block the directly-conjugated anti-cytokine antibodies with excess amounts of cognate ligand.Buffers used for intracellular staining can have varying effects. eBioscience antibodies are optimized using eBioscience Foxp3 staining buffer set (cat. 00-5523) or eBioscience IC Fixation Buffer (cat. 00-8222). All antibodies to cytokines tested have stained appropriately using the Foxp3 buffers. Please contact Technical support for more information. Precautionary Note: Prior to using antibodies, do a quick spin to recover the maximum volume from the vials. We monitor our conjugated antibodies to make sure they are void of aggregation. Some protocols include a step of airfuging the antibody prior to staining to further clear aggregates. For optimal performance of fluorochrome conjugated antibodies, store at 4°C in the dark. Do not freeze. When staining, please note that fixation and/or delayed analysis may yield poor signal-to-noise for certain antigens. For best results, stain fresh mouse cells and analyze soon after staining. The following protocol is for intracellular staining of Human Foxp3 (clone PCH101, cat. 4776). Please refer to specific clones for the corresponding protocol. We have also determined that this kit is suitable for most cytokine staining procedures. It is critical to use the Foxp3 Staining Buffer Set (cat. 00-5523). The buffer set is included with all Foxp3 Staining Sets.Prior to staining, dilute the Fixation/Permeabilization Concentrate (1 part) into the Fixation/Permeabilization Diluent (3 parts) to the desired volume of Fixation/Permeabilization working solution. This buffer should not be stored for more than 1 day. For example: For 12 samples, use 3 ml Fixation/Permeabilization Concentrate and 9 ml Fixation/Permeabilization Diluent. Mouse/Human Granzyme B (GB11):Left: Human peripheral blood cells were stimulated for 2 days with IL-2. The cells were surface stained with FITC CD56 (MEM188) (Cat. No. 11-0569) and stained intracellularly with PE GB11. Quadrants demarcate boundary for isotype controls. Right: Mouse splenocytes were stimulated for 3 days with IL-2. Cells were surface stained with APC CD49d (DX5) (Cat. No. 17-5971) and subsequently stained intracellularly with PE GB11. Human IL-17 (eBio64CAP17):Human PBMCs were stimulated with TPA/ionomycin in the presence of monensin for 5 hours. The cells were fixed and permeabilized and intracellularly stained with anti-human CD4, clone RPA-T4, (Cat. No. 17-0049) and Alexa Fluor® 488 anti-human IL-17 (Cat. No. 53-7178). Isotype control on the left and anti-IL-17 on the right. Cells in the lymphocytes gate were used for analysis. Mouse Cytokines: Intracellular Staining Quick Guide Mouse Cytokine Cell Source Activation Incubation Time Restimulation Intracellular Block Antibody GM-CSF mouse spleen ConA (3ug/ml) (2d)/IL-2 (20ng/ml)+IL-4 (20ng/ml) (3d) 2d/3d anti-CD3 (10ug/ml immobilized) + anti-CD28 (2ug/ml soluble) 5hr Brefeldin A MP1-22E9 IFN-γ mouse spleen ConA (3ug/ml) (2d)/IL-2 (20ng/ml)+IL-4 (20ng/ml) (3d) 2d/3d anti-CD3 (10ug/ml immobilized) + anti-CD28 (2ug/ml soluble) 5hr Brefeldin A XMG1.2 IL-1α mouse PEC mIFNγ (100ng/ml) (2hr)/LPS (100ng/ml)(22hr) 2hr/22hr - Brefeldin A ALF-161 IL-1β mouse PEC mIFNγ (100ng/ml) (2hr)/LPS (100ng/ml)(22hr) 2hr/22hr - Brefeldin A polyclonal IL-2 mouse spleen ConA (3ug/ml) (2d)/IL-2 (20ng/ml)+IL-4 (20ng/ml) (3d) 2d/3d anti-CD3 (10ug/ml immobilized) + anti-CD28 (2ug/ml soluble) 5hr Brefeldin A JES6-5H4 IL-4 mouse spleen ConA (3ug/ml) (2d)/IL-2 (20ng/ml)+IL-4 (20ng/ml) (3d) 2d/3d anti-CD3 (10ug/ml immobilized) + anti-CD28 (2ug/ml soluble) 5hr Brefeldin A BVD6-24G2,11B11 IL-5 NEW! mouse splenic CD4 ConA (3ug/ml) (2d)/IL-2 (20ng/ml)+IL-4 (20ng/ml) (3d) 2d/3d anti-CD3 (10ug/ml immobilized)+anti-CD28 (2ug/ml soluble) 5hr Brefeldin A TRFK5 IL-6 mouse PEC mIFNγ (100ng/ml) (2hr)/LPS (100ng/ml)(22hr) 2hr/22hr - Brefeldin A MP5-20F3 IL-10 mouse spleen ConA (3ug/ml) (2d)/IL-2 (20ng/ml)+IL-4 (20ng/ml) (3d) 2d/3d anti-CD3 (10ug/ml immobilized) + anti-CD28 (2ug/ml soluble) 5hr Brefeldin A JES5-16E3,JES5-2A5 IL-12/IL-23 (p40) mouse PEC mIFNγ (100ng/ml) (2hr)/LPS (100ng/ml) (22hr) 2hr/22hr - Brefeldin A C17.8 IL-17A NEW! CD4+CD25- T cells from mouse spleen plus day 10 bone marrow-derived dendritic cells anti-CD3, anti-IL-4, anti-IFN-γ, recTGF-β, recIL-6 4d PMA/Iono 5hr Monensin eBio17B7 IL-17F NEW! mouse CD4 IL-17 induction 6d PMA/Iono 5hr Monensin eBio18F10 MCP-1/ CCL2 NEW! mouse PEC LPS 100ng/ml 24hr - Brefeldin A 2H5 TNF-α mouse PEC mIFNγ (100ng/ml) (2hr)/LPS (100ng/ml)(22hr) 2hr/22hr - Brefeldin A MP6-XT22,TN3-19 Annotations: mouse PEC=mouse thioglycolate-elicited peritoneal macrophages; ConA=Concanavalin A; Iono=Ionomycin; LPS=Lipopolysaccharide; PMA=Phorbol Myristate Acetate; 2d=2 day culture; 5hr=5 hour culture Human Cytokines: Intracellular Staining Quick Guide Human Cytokine Cell Source Activation Incubation Time Restimulation Intracellular Block Antibody IFNα2 PMBC CpG A ODN2216 (20ug/ml) 20 hours - Brefeldin A (added 2-4 hr post stimulation) 225.C IFN-γ PBMC PMA (30-50ng/ml)/Iono (1ug/ml) 5hr - Brefeldin A 4S.B3 IL-1α PBMC LPS 100ng/ml 24hr - Brefeldin A 364/3B3-14 IL-1β NEW! PBMC LPS 100ng/ml 24hr - Brefeldin A CRM56 IL-1RA PBMC LPS 100ng/ml 24hr - Brefeldin A CRM17 IL-2 PBMC PMA (30-50ng/ml)/Iono (1ug/ml) 5hr - Brefeldin A MQ1-17H12 IL-4 PBMC anti-CD3 (10µg/ml, immobilized) + anti-CD28 (2µg/ml, soluble) + IL-2 (10ng/ml) + IL-4 (20ng/ml) (2d); IL-2 (10ng/ml) + IL-4 (20ng/ml) (3d) 2d/3d PMA (5ng/ml) + Ionomycin (500ng/ml) (4hr) Brefeldin A MP4-25D2,8D4-8 IL-5 CD4 anti-CD3 (10µg/ml, immobilized) + anti-CD28 (2µg/ml, soluble) + IL-2 (10ng/ml) + IL-4 (20ng/ml) (2d); IL-2 (10ng/ml) + IL-4 (20ng/ml) (3d) 2d/3d PMA (5ng/ml) + Ionomycin (500ng/ml) (4hr) Brefeldin A TRFK5,JES1-5A10 IL-6 PBMC LPS 100ng/ml 5hr - Brefeldin A MQ2-13A5 IL-10 PBMC Th2 polarizing cultures 6d PMA (50ng/ml) + ionomycin (1ug/ml) Monensin JES3-9D7 IL-12/ IL-23 (p40) PBMC hIFNγ (100ng/ml) (2hr)/LPS (100ng/ml) (22hr) 2hr/22hr - Brefeldin A C8.6 IL-13 NEW! CD4 anti-CD3 (10µg/ml, immobilized) + anti-CD28 (2µg/ml, soluble) + IL-2 (10ng/ml) + IL-4 (20ng/ml) (2d); IL-2 (10ng/ml) + IL-4 (20ng/ml) (3d) 2d/3d PMA (5ng/ml) + Ionomycin (500ng/ml) (4hr) Brefeldin A PVM13-1 IL-17A NEW! PBMC PMA (30-50ng/ml)/Iono (1ug/ml) 5hr Monensin eBio64CAP17,eBio64DEC17 IL-21 PBMC PMA (30-50ng/ml)/Iono (1ug/ml) 4-7hr or 12-18hr Brefeldin A eBio3A3-N2 MCP-1/ CCL2 NEW! PBMC LPS 100ng/ml 24hr - Brefeldin A 2H5,5D3-F7 TNF-α PBMC PMA (30-50ng/ml)/Iono (1ug/ml) 5hr - Brefeldin A MAb11 TNF-β PBMC anti-CD3 (10µg/ml, immobilized) + IL-2 (10ng/ml) (2d); IL-2 (10ng/ml) (3d) 2d/3d PMA (5ng/ml) + Ionomycin (500ng/ml) (6hr) Brefeldin A 359-81-11 Annotations: Iono=Ionomycin; PMA=Phorbol Myristate Acetate; LPS=Lipopolysaccharide; 2d=2 day culture; 5hr=5 hour culture; LPS for activation of human PBMC obtained from Sigma (#L-8274) Non-Cytokine Proteins: Intracellular Staining Quick Guide Antigen Antibody Mouse/Rat Bcl-2 10C4 Mouse CTLA-4 (CD152) UC10-4B9 Human CTLA-4 (CD152) 14D3 Mouse/Human/Rat Cytochrome C 6H2 Human Foxp3 PCH101 Mouse Foxp3 FJK-16s Mouse/Human Granzyme B eBioGrB Mouse Langerin (CD207) eBioRMUL.2 Human Nanog hNanog.1 Human PCNA (Proliferating Cell Nuclear Antigen) PC10 Mouse Perforin eBioOMAK-D Human Perforin dG9 Mouse SLP-76 MS76 Human SLP-76 HS76 Human TLR3 TLR3.7 Mouse TLR9 M9.D6 Human TLR9 eB72-1665 Mouse/Human ZAP-70 1E7.2 Intracellular Cytokine Staining Protocol
Foxp3 Staining Protocol